Legence Corp (LGN) PT Raised to $101 at Stifel
Tweet
Share
E-mailGet Alerts LGN Hot Sheet
Price: $68.68 +5.71%
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Stifel analyst Brian Brophy raised the price target on Legence Corp (NASDAQ: LGN) to $101.00 (from $77.00) while maintaining a Buy rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Nomura/Instinet Downgrades Lloyds Metals & Energy Ltd (LLOYDSME:IN) to Neutral
- Merit Medical Systems, Inc. (MMSI) PT Raised to $97 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
